ArticleBioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy2021

Factors Influencing Infusion-Related Reactions Following Dosing of Reference Rituximab and PF-05280586, a Rituximab Biosimilar.

Jocelyn Courville et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.